The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease

Gut

Volumn 64, Issue 3, 2015, Pages 406-417

  Olivares, M ^a   Neef, A ^a   Castillejo, G ^b   De Palma, G ^a   Varea, V ^c   Capilla, A ^d   Palau, F ^d   Nova, E ^e   Marcos, A ^e   Polanco, I ^f   Ribes Koninckx, C ^g   Ortigosa, L ^h   Izquierdo, L ^a   Sanz, Y ^a  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

^b HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^e INSTITUTE OF FOOD SCIENCE   (Spain)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^g HOSPITAL UNIVERSITARIO LA FE   (Spain)

^h HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ2 ANTIGEN; RNA 16S; GENETIC MARKER; HLA DQ ANTIGEN;

ACTINOBACTERIA; ARTICLE; BIFIDOBACTERIACEAE; BIFIDOBACTERIUM; BREAST FEEDING; CELIAC DISEASE; CLOSTRIDIACEAE; CLOSTRIDIUM; COHORT ANALYSIS; CONTROLLED STUDY; CORYNEBACTERIUM; DISEASE ASSOCIATION; DYSBIOSIS; ENTEROBACTERIACEAE; ESCHERICHIA; FECES MICROFLORA; FIRMICUTES; GEMELLA; GENETIC RISK; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HIGH RISK INFANT; HOST; HUMAN; INFANT; INTESTINE FLORA; PROSPECTIVE STUDY; PROTEOBACTERIA; PYROSEQUENCING; RAOULTELLA; REAL TIME POLYMERASE CHAIN REACTION; RELATIVE; RISK ASSESSMENT; RNA GENE; SHIGELLA; VAGINAL DELIVERY; FECES; FEMALE; GENETIC MARKER; GENETICS; INTESTINE; MALE; MICROBIOLOGY; MICROFLORA; RISK FACTOR;

CELIAC DISEASE; CLOSTRIDIUM; FECES; FEMALE; GENETIC MARKERS; GENOTYPE; HAPLOTYPES; HLA-DQ ANTIGENS; HUMANS; INFANT; INTESTINES; MALE; MICROBIOTA; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 84922385878     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2014-306931     Document Type: Article

References (47)

1. Fallang L-E, Bergseng E., Hotta K, et al. Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation. Nature Immunology 2009; 10:1096-101.
2. Dubois PC, van Heel DA. Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease. Clin Exp Immunol 2008; 153:162-73.
3. Di Sabatino A, Corazza GR. Coeliac disease. Lancet 2009; 373:1480-93.
4. Rossi M, Schwartz KB. Editorial: Celiac disease and intestinal bacteria: not only gluten? J Leukoc Biol 2010; 87:749-51.
5. Romanos J, Rosén A, Kumar V., et al.; PreventCD Group. Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants. Gut 2014; 63:415-22.
6. Ivarsson A, Hernell O, Stenlund H., et al. Breast-feeding protects against celiac disease. Am J Clin Nutr 2002; 75:914-21.
7. Sandberg-Bennich S, Dahlquist G, Källén B. Coeliac disease is associated with intrauterine growth and neonatal infections. Acta Paediatr 2002; 91:30-3.
8. Sanz Y, De Palma G, Laparra M. Unraveling the ties between celiac disease and intestinal microbiota. Int Rev Immunol 2011; 30:207-18.
9. Sellitto M, Guoyun B, Serena G., et al. A Proof of Concept of Microbiome-Metabolome Analysis and Delayed Gluten Exposure on Celiac Disease Autoimmunity in Genetically At-Risk Infants. PLoS One 2012; 7:e33387.
10. Mårild K, Stephansson O, Montgomery S., et al. Pregnancy outcome and risk of celiac disease in offspring: a nationwide case-control study. Gastroenterology 2012; 142:39-5.
11. Mårild K, Ye W, Lebwohl B., et al. Antibiotic exposure and the development of coeliac disease: a nationwide case-control study. BMC Gastroenterol 2013; 13:109.
12. Madan JC, Salari RC, Saxena D, et al. Gut microbial colonization in premature neonates predicts neonatal sepsis. Arch Dis Child Fetal Neonatal Ed 2012; 97:F456-62.
13. El Aidy S, Hooiveld G, Tremaroli V., et al. The gut microbiota and mucosal homeostasis: colonized at birth or at adulthood, does it matter? Gut Microbes 2013; 4:118-24.
14. Laparra M, Olivares M, Sanz Y. Role of Gut Microbes in Celiac Disease Risk and Pathogenesis. In: Rampertab DS, Mullin GE, eds. Celiac Disease. New York: Springer, 2013:81-94.
15. Kalliomaki M, Kirjavainen P, Eerola E., et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001; 107:129-34.
16. de Meij TG, Budding AE, Grasman M.E., et al. Composition and diversity of the duodenal mucosa-associated microbiome in children with untreated coeliac disease. Scand J Gastrenterol 2013; 48:530-6.
17. Nadal I, Donat E, Ribes-Koninckx C, et al. Imbalance in the composition of the duodenal microbiota of children with coelic disease. J Med Microbiol 2007; 56:1669-74.
18. Collado MC, Donat E, Ribes-Koninckx C, et al. Specific duodenal and faecal bacterial groups are associated with pediatric celiac disease. J Clin Pathol 2009; 62:264-69.
19. Bourma G, Strober W. The immunological and genetics basis of inflammatory bowel disease. Nat Rev Immunol 2003; 3:521-33.
20. Elinav E, Strowig T, Kau A.L., et al. NLRP & inflammasone regulates colonic microbial ecology and risk for colitis. Cell 2011; 145:745-57.
21. Li E, Hamm CM, Gulati A.S., et al. Inflammatory bowel diseases phenotypt, C. difficile and NOD2 genotypa are associated with shifts in human ileum associated microbial composition. PLoS One 2012; 7:e26284.
22. De Palma G, Capilla A, Nadal I., et al. Interplay Between Human Leukocyte antigen Genes and Microbial Colonization Process of the Newborn Intestine. Curr Issues Mol Biol 2010; 12:1-10.
23. De Palma G, Capilla A, Nova E., et al. Influence of Milk-Feeding Type and Genetic Risk of Developing Coeliac Disease on Intestinal Microbiota of Infants: The PROFICEL study. PLoS One 2012; 7:e30791.
24. Faust K, Raes J. Microbial interactions: from networks to models. Nat Rev Microbiol 2012; 10:538-50.
25. Andersson AF, Lindberg M, Jakobsoon H., et al. Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One 2008; 3:e2836.
26. Edgar RC, Haas BJ, Clemente J.C., et al. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 2011; 27:2194-200.
27. Schloss PD, Westcott SL, Ryabin T, et al. Introducing mothur: Open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 2009; 75:7537-41.
28. Legendre P, Legendre A. Complex ecological data sets. In: Legendre P, Legendre A, eds. Numerical Ecology. Amsterdam: Elsevier, 1998:247-302.
29. Legendre P, Legendre A. Ecological resemblance. In: Legendre P, Legendre A, eds. Numerical Ecology. Amsterdam: Elsevier, 1998:1-48.
30. Matsuki T, Watanabe K, Fujimoto J., et al. Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol 2002; 68:5445-51.
31. Malinen E, Kassinen A, Rinttila T., et al. Comparison of real-time PCR with SYBR Green I or 59-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria. Microbiology 2003; 149:269-77.
32. Birnboim HC, Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res 1979; 7:1513-23.
33. Olivares M, Laparra JM, Sanz Y. Host genotype, intestinal microbiota and inflammatory disorders. Br J Nutr 2012; 14:1-6.
34. Sánchez E, De Palma G, Capilla A, et al. Influence of environmental and genetic factors linked to celiac disease risk on infant gut colonization by Bacteroides species. Appl Environ Microbiol 2011; 77:5316-23.
35. de Goffau MC, Luopajärvi K, Knip M., et al. Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes 2013; 62:1238-44.
36. Bull-Otterson L, Feng W, Kirpich I., et al. Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment. PLoS One 2013; 8:e53028.
37. Sander GR, Cummins AG, Henshall T, et al. Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins. FEBS Lett 2005; 579:4851-65.
38. Sellitto M, Bai G, Serena G., et al. Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. PLoS One 2012; 7:e33387.
39. Palmer C, Bik EM, DiGiulio D.B., et al. Development of the Human Infant Intestinal Microbiota. PLoS Biol 2007; 5:e177.
40. Kennedy N, Walker AK, Berry S, et al. The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16S rRNA gene sequencing. PLoS ONE 2014; 9: e88982.
41. Frank DN, Robertson CE, Hamm C.M., et al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 2011; 17:179-84.
42. Bezirtzoglou E, Tsiotsias A, Welling GW. Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH). Anaerobe 2011; 17:478-82.
43. Fan W, Huo G, Li X., et al. Diversity of the intestinal microbiota in different patterns of feeding infants by Illumina high-throughput sequencing. World J Microbiol Biotechnol 2013; 29:2365-72.
44. Wang Y, Hoenig JD, Malin K.J., et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis investigation. ISME J 2009; 3:944-54.
45. Giongo A, Gano KA, Crabb D.B., et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J 2011; 5:82-91.
46. Turnbaugh PJ, Hamady M, Yatsunenko T., et al. A core gut microbiome in obese and lean twins. Nature 2009; 457:480e4.
47. Sim K, Cox MJ, Wopereis H, et al. Improved Detection of Bifidobacteria with Optimised 16S rRNA-Gene Based Pyrosequencing. PLoS ONE 2012; 7:e32543.